MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Goldshield

Goldshield
Goldshield is a global Pharmaceutical and Healthcare company headquartered in the UK, seeking new product opportunities in Pain & Anesthesia, Joints & Musculoskeletal, Cardiology, Ophthal, Derma.

The company in detail

Profile

Goldshield is a global Pharmaceutical company, headquartered in the UK and listed on the London Stock Exchange.  The company  also has offices in the US and India and has achieved rapid growth both organically and through astute product acquisitions.

Goldshield has a professional team with knowledge and experience in the following areas; Acquisitions, integration of acquisitions, in-licensing, developing and implanting growth strategies, marketing products and distributor management.

The company is dedicated to ensuring success and building strong relationships with customers and suppliers, which means that it is well positioned to partner with other companies to successfully commercialize products in a wide range of therapeutic areas and market settings. The key therapy areas of interest would be:  Pain & Anesthesia, Joints &  Musculoskeletal, Cardiology, Ophthalmalogy, Dermatology.

Goldshield has an extensive distributor base and distribution channels which cover more than 60 countries, access to a wide customer base of pharmacies, hospitals and doctors and an established worldwide network of manufacturing partners which it has built over the last 15 years.

Partnering strategy/interests

Goldshield Pharmaceuticals is setting up a Business Development Forum & would likr to invite similar sized European companies with teh presence in 2 to 3 key EU territories with a focus within licensing products from various therapeutic categories to join in the discussion & form strategic alliances.

The purpose of the Forum is to allow members to license in & supply innovative drugs in the European markets using the forum as a platform for leveraging their existing sales & marketing infrastructure/expertise, products & R&D pipeline & share information between the partners in terms of Business Development, In Licensing, Strategic Marketing & Territory knowledge.

Goldshield invites all pharmaceutical companies having an in depth knowledge of their own markets to form a network of professional sales & marketing expertise in the selected markets & provide services to teh companies/partners not present in those markets.

Goldshield aims to continue to grow through the following:

•    Acquisition (strategic alliances)
•    Specialized product development
•    In-licensing

The company is interested in hearing from companies who can offer any opportunities in these areas.

In-licensing

Seeking established pharmaceutical products in the European market More
Licensing or acquisition of an established hospital pharmaceutical European product More
Licensing or acquisition of anaesthetic products for the European market More
Licensing or acquisition of dermatological products for the European market More
Licensing or acquisition of ophthalmology products for the European market. More
Exclusive license and supply for UK and Ireland More
Biopharmaceuticals More
Ready tablet or injectable of the above product More
Seeking distribution for UK for tablet More
Seeking injections of the following medications; Esmolol, Cyclosporine, Ketoprofen & Tramadol More
Need to in-license Ibuprofen Oral suspension for UK More
Goldshield is looking to in license the Cyclizine Products More
In licensing Products for European territories More
Pain management Produts In - Licensing More
In Licensing for the UK More
Dermal Fillers with long lasting facial sculpting effect More
Seeking a paracetamol injection for license and supply in the UK More
pre-filled syringes for critical care- apomorphine More
urgently need manufacturer for EU More

R&D

To view this information, you must subscribe to PL Intelligence.

Partnerships

To view this information, you must subscribe to PL Intelligence.

Senior management

To view this information, you must subscribe to PL Intelligence.

Board of directors

To view this information, you must subscribe to PL Intelligence.

Contact details

Business Development
Licensing

Contact directly

Head office

Goldshield
NLA Tower
12-16 Addiscombe Road
Croydon
Surrey
CR0 0XT
United Kingdom

Company figures

Formed: 1991

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us